Perspective Therapeutics (CATX) Tax Provisions (2023)
Perspective Therapeutics (CATX) posted Tax Provisions of $10.5 million for Q4 2023, up 199.9% sequentially from -$10.5 million in Q1 2023.
Perspective Therapeutics (CATX) Tax Provisions (2023) Analysis & Trends
Perspective Therapeutics has reported Tax Provisions for 1 years, with the latest figure at $10.5 million in Q4 2023.
- Quarterly Tax Provisions changed N/A year-over-year to $10.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$10000.0 (changed N/A YoY) and the FY2023 annual result came in at -$10000.0, changed N/A from the prior year.
- Tax Provisions improved to $10.5 million in Q4 2023 per CATX's latest filing, from -$10.5 million in the prior quarter.
- Over five years, Tax Provisions peaked at $10.5 million in Q4 2023 and troughed at -$10.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | 596.00 Mn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 288.00 Mn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 155.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 278.40 Mn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 68.40 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 119.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -185.98 Mn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 72.50 Mn |
| 10 | Perspective Therapeutics | 384.88 Mn | 384.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 10.49 Mn |
| Mar 31, 2023 | -10.50 Mn |